Adherence of Apixaban and Warfarin in Patients With Atrial Fibrillation in Real-world Setting in Sweden

Trial Profile

Adherence of Apixaban and Warfarin in Patients With Atrial Fibrillation in Real-world Setting in Sweden

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 May 2016

At a glance

  • Drugs Apixaban (Primary) ; Warfarin
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Sponsors Bristol-Myers Squibb
  • Most Recent Events

    • 17 May 2016 Status changed from active, no longer recruiting to completed.
    • 14 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top